Sit-to-stand test for people with hemophilia
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study compares how well people with hemophilia can do the sit-to-stand test (standing up from a chair repeatedly for 30 seconds) to people without hemophilia. It helps understand leg strength and function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have hemophilia type A or B
- You are between 18 and 35 years old
- You can walk on your own
- You have not had a joint bleeding episode in the last 3 months
- You are willing to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called KN057 for people with hemophilia A or B, with or without inhibitors, to see if it helps prevent bleeding. It is for people who still have frequent bleeding episodes despite current treatments.
This study looks at tissue from joints affected by hemophilia to find new markers that could help understand and treat joint damage. It is for people with severe hemophilia who need a joint procedure like a fluid removal, synovectomy, or joint replacement.
This study checks if two simple walking and balance tests are reliable for people with hemophilia who have had joint bleeds. It may help doctors better track joint health and function.
This study looks at what helps or limits physical activity in adults with hemophilia who have joint damage in their legs. It may help doctors find better ways to support patients in staying active.
This study looks at how hemophilia A affects joint health, balance, and quality of life in adults. Researchers will assess your joints and balance to understand the relationship between joint damage and everyday function.
This study compares how well children with hemophilia use their arms and hands compared to healthy children. If your child has hemophilia A or B, is on regular treatment, and has no inhibitors or recent bleeds in the arm, they may be able to join.
Hear when a new Hemophilia A and B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.